Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. - Kuang,M.; Peng,B.G.; Lu,M.D.; Liang,L.J.; Huang,J.F.; He,Q.; Hua,Y.P.; Totsuka,S.; Liu,S.Q.; Leong,K.W.; Ohno,T. (Clin Cancer Res, 2004)